scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1029695992 |
P356 | DOI | 10.1186/1745-6215-9-17 |
P932 | PMC publication ID | 2335090 |
P698 | PubMed publication ID | 18366798 |
P5875 | ResearchGate publication ID | 5485266 |
P50 | author | Carrol Gamble | Q64496254 |
P2093 | author name string | Suresh Victor | |
Alan M Weindling | |||
Mark A Turner | |||
Mohammed Didi | |||
Sze M Ng | |||
P2860 | cites work | Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial | Q45170114 |
Is thyroid inadequacy during gestation a risk factor for adverse pregnancy and developmental outcomes? | Q45248848 | ||
Postnatal thyroxine supplementation in infants less than 32 weeks' gestation: effects on pulmonary morbidity. | Q45988461 | ||
Results of controlled double-blind study of thyroid replacement in very low-birth-weight premature infants with hypothyroxinemia | Q47242101 | ||
Head circumference as an index of brain weight in the fetus and newborn | Q47326419 | ||
The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants | Q47340257 | ||
Magnetic resonance imaging and T2 relaxometry of cerebral white matter and hippocampus in children born preterm | Q48221047 | ||
Investigations on iodothyronine deiodinase activity in the maturing rat brain | Q48357794 | ||
The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. | Q49051032 | ||
Abnormal cerebral structure is present at term in premature infants. | Q49086898 | ||
Extreme prematurity--the continuing dilemma. | Q50982306 | ||
The effect of neonatal thyroidectomy on myelination in the rat brain | Q51160395 | ||
Developmental trends in cord and postpartum serum thyroid hormones in preterm infants. | Q52085898 | ||
Caudate and hippocampal volumes, intelligence, and motor impairment in 7-year-old children who were born preterm. | Q52093890 | ||
Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation. | Q52196743 | ||
The development of the foetal thyroid: in utero ultrasonographic measurements. | Q52243868 | ||
Periventricular white matter injury in the premature infant is followed by reduced cerebral cortical gray matter volume at term | Q57242179 | ||
Thyroid Function in Very Preterm Infants: Influences of Gestational Age and Disease | Q59361851 | ||
Brain metabolite changes on in vivo proton magnetic resonance spectroscopy in children with congenital hypothyroidism | Q72575804 | ||
Thyroxine administration to infants of less than 30 weeks' gestational age does not increase plasma triiodothyronine concentrations | Q72925453 | ||
L-thyroxine treatment of preterm newborns: clinical and endocrine effects | Q73486305 | ||
Intellectual outcome at 12 years of age in congenital hypothyroidism | Q78063006 | ||
Transient hypothyroxinaemia in preterm infants | Q79322467 | ||
Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants | Q24243042 | ||
Neurologic and developmental disability at six years of age after extremely preterm birth | Q28301325 | ||
Ultrasound of the thyroid gland in the newborn: normative data | Q33184926 | ||
Thyroid function in the preterm infant | Q33536321 | ||
Hormone synthesis and storage in the thyroid of human preterm and term newborns: effect of thyroxine treatment | Q33685942 | ||
Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? | Q34092143 | ||
Measurement of the subarachnoid space by ultrasound in preterm infants | Q35291642 | ||
Neurocognitive outcome after very preterm birth | Q35294356 | ||
The EPICure study: associations and antecedents of neurological and developmental disability at 30 months of age following extremely preterm birth | Q35296445 | ||
Iodine deficiency associated with parenteral nutrition in extreme preterm infants | Q35556469 | ||
Transient adrenocortical insufficiency of prematurity and systemic hypotension in very low birthweight infants | Q35556541 | ||
The EPICure study: growth and associated problems in children born at 25 weeks of gestational age or less | Q35571736 | ||
Transient hypothyroxinaemia associated with developmental delay in very preterm infants | Q35628307 | ||
Adrenocortical function and dysfunction in the fetus and neonate | Q35687876 | ||
Role of thyroid hormone during early brain development | Q35956761 | ||
Statistical aspects of research methodology | Q37061351 | ||
Are there critical periods for brain growth in children born preterm? | Q37168050 | ||
Thyroid Development and Disorders of Thyroid Function in the Newborn | Q40123408 | ||
Synaptogenesis, heterochrony and epigenesis in the mammalian neocortex. | Q41595074 | ||
Low serum thyroxine on initial newborn screening is associated with intraventricular hemorrhage and death in very low birth weight infants | Q41753114 | ||
Low plasma triiodothyronine concentrations and outcome in preterm infants | Q41992608 | ||
Reversal of abnormalities of myelination by thyroxine therapy in congenital hypothyroidism: localized in vivo proton magnetic resonance spectroscopy (MRS) study | Q42539876 | ||
Low triiodothyronine concentration in preterm infants and subsequent intelligence quotient (IQ) at 8 year follow up. | Q43187545 | ||
The influence of etiology and treatment factors on intellectual outcome in congenital hypothyroidism | Q43843725 | ||
A longitudinal assessment of thyroid hormone concentrations in preterm infants younger than 30 weeks' gestation during the first 2 weeks of life and their relationship to outcome | Q43875704 | ||
Free thyroxine levels during the first weeks of life and neurodevelopmental outcome until the age of 5 years in very preterm infants | Q44121233 | ||
Pulmonary effects of triiodothyronine (T3) and hydrocortisone (HC) supplementation in preterm infants less than 30 weeks gestation: results of the THORN trial--thyroid hormone replacement in neonates | Q44266961 | ||
Adrenal and thyroid axis function in preterm ventilated baboons | Q44379046 | ||
A randomized, masked study of triiodothyronine plus thyroxine administration in preterm infants less than 28 weeks of gestational age: hormonal and clinical effects | Q44664155 | ||
Evidence for developmental hypopituitarism in ill preterm infants | Q44885330 | ||
The hypothalamic-pituitary-thyroid axis in preterm infants; changes in the first 24 hours of postnatal life | Q44924334 | ||
P921 | main subject | preterm infant | Q45051448 |
P304 | page(s) | 17 | |
P577 | publication date | 2008-03-26 | |
P1433 | published in | Trials | Q7840023 |
P1476 | title | TIPIT: A randomised controlled trial of thyroxine in preterm infants under 28 weeks' gestation | |
P478 | volume | 9 |
Q37014390 | An explanatory randomised placebo controlled trial of levothyroxine supplementation for babies born <28 weeks' gestation: results of the TIPIT trial |
Q35135932 | Clinical trials of medicines in neonates: the influence of ethical and practical issues on design and conduct |
Q44052535 | Do maternal factors influence neonatal thyroid status in the extreme premature infant? |
Q64235802 | Extreme Premature Small for Gestational Age Infants Have Appropriate Catch-up Growth at Term Equivalence Compared with Extreme Premature Appropriate for Gestational Age Infants |
Q89763152 | Neurodevelopmental Outcomes at 42 Months After Thyroxine Supplementation in Infants Below 28 Weeks' Gestation: A Randomized Controlled Trial |
Q36355944 | Performance metrics after changes in screening protocol for congenital hypothyroidism |
Q30493913 | TIPIT: a randomised controlled trial of thyroxine in preterm infants under 28 weeks gestation: magnetic resonance imaging and magnetic resonance angiography protocol |
Q37417669 | The impact of networks on clinical trials in the United Kingdom |
Q64275625 | Treatment preference and recruitment to pediatric RCTs: A systematic review |
Search more.